Healthline
Medscape
August 2, 2024
TOPLINE: Upadacitinib, an oral Janus kinase (JAK) 1 inhibitor, showed an 80% complete response rate in patients with granulomatous cheilitis, with no serious adverse events, in […]
August 2, 2024
Newborn screening for neonatal vitamin B12 deficiency may lead to a fourfold reduction in chances of developing symptomatic vitamin B12 in the first year of life […]
August 2, 2024
Geographic spread of the ticks that most often cause Lyme disease in the United States and a rise in incidence of bites, resulting in 476,000 new […]
August 1, 2024
(Reuters) – Utah’s highest court on Thursday refused to allow the enforcement of a near-total abortion ban while a lower court judge considers a challenge to […]
